Stockreport

Gilead's Arcus Pullback and Idvynso HIV Challenge Might Change The Case For Investing In GILD [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF programs while keeping time-limited options on select assets like AB801, AB598, AB102 and a TNF inhibitor. Around the same time, Merck's newly approved Idvynso, a two- [Read more]